SKI‐G‐801, an AXL kinase inhibitor, blocks metastasis through inducing anti‐tumor immune responses and potentiates anti‐PD‐1 therapy in mouse cancer models.
Saved in:
| Title: | SKI‐G‐801, an AXL kinase inhibitor, blocks metastasis through inducing anti‐tumor immune responses and potentiates anti‐PD‐1 therapy in mouse cancer models. |
|---|---|
| Authors: | Synn, Chun‐Bong1,2, Kim, Sung Eun1, Lee, Hee Kyu3, Kim, Min‐Hwan4, Kim, Jae Hwan1, Lee, Ji Min2, Jo, Ha Ni1, Lee, Wongeun5, Kim, Dong Kwon1, Byeon, Youngseon1, Kim, Young Seob1, Yun, Mi Ran5, Park, Chae‐Won1, Yun, Jiyeon1, Lim, Sangbin1, Heo, Seong Gu1, Yang, San‐Duk1, Lee, Eun Ji1, Lee, Seul1, Choi, Hunmi1 |
| Source: | Clinical & Translational Immunology. 2022, Vol. 11 Issue 1, p1-14. 14p. |
| Database: | Academic Search Ultimate |
|
Full text is not displayed to guests.
Login for full access.
|
|
| ISSN: | 20500068 |
|---|---|
| DOI: | 10.1002/cti2.1364 |
